World's Best Scientists 2026 revealed!
Award Badge
Medicine
Germany
2023

D-Index & Metrics

Medicine

D-Index
128
Citations
73645
World Ranking
2675
National Ranking
132

Research.com Recognitions

  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Arnold Ganser is affiliated with Hannover Medical School in Germany. Their primary research field is Medicine, with a focus on several subfields including Hematology, Molecular Biology, Genetics, Public Health, Environmental and Occupational Health, and Oncology.

The scientist's research concentrates on key topics such as Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, CAR-T Cell Therapy Research, and Protein Degradation and Inhibitors.

Ganser has contributed to numerous recent papers, including:

  • Treatment of Relapsed Acute Myeloid Leukemia, 2020, Current Treatment Options in Oncology
  • Redefining and Measuring Transplant Conditioning Intensity in Current Era: A Study in Acute Myeloid Leukemia Patients, 2020, Bone Marrow Transplantation
  • Prothrombotic Immune Thrombocytopenia After COVID-19 Vaccination, 2021, Blood
  • Unified Classification and Risk-Stratification in Acute Myeloid Leukemia, 2022, Nature Communications
  • Reappearance of Effector T Cells Is Associated with Recovery from COVID-19, 2020, EBioMedicine

Frequent collaborators include:

  • Michael Heuser
  • Felicitas Thol
  • Konstanze Döhner
  • Hartmut Döhner
  • Arnon Nagler

Ganser's publications are frequently found in venues such as Blood, Bone Marrow Transplantation, Leukemia, HemaSphere, and Haematologica. These journals serve as regular platforms for their work in hematologic malignancies and related biomedical research.

In addition to journal articles, Ganser has contributed to book publications, including one titled Maritime Mobilities in Anglophone Literature and Culture, published in 2023 under the publisher Maritime literature and culture.

Best Publications

  • Genomic Classification and Prognosis in Acute Myeloid Leukemia

    Elli Papaemmanuil;Moritz Gerstung;Lars Bullinger;Verena I Gaidzik

  • Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

    Kai C Wollert;Gerd P Meyer;Joachim Lotz;Stefanie Ringes Lichtenberg

  • Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

    Richard F. Schlenk;Konstanze Döhner;Jürgen Krauter;Stefan Fröhling

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

    Gerd P. Meyer;Kai C. Wollert;Joachim Lotz;Jan Steffens

  • Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium

    Michael Hofmann;Kai C. Wollert;Gerd P. Meyer;Alix Menke

  • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri

  • Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults

    D Hoelzer;E Thiel;H Loffler;T Buchner

  • Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

    Michael Lübbert;Stefan Suciu;Liliana Baila;Björn Hans Rüter

  • TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

    Frank G. Rücker;Richard F. Schlenk;Lars Bullinger;Sabine Kayser

  • Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

    David M. Good;Petra Zürbig;Àngel Argilés;Hartwig W. Bauer

  • A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

    Pierre Fenaux;Aristoteles Giagounidis;Dominik Selleslag;Odile Beyne-Rauzy

  • Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

    Nicola Gökbuget;Michael Kneba;Thorsten Raff;Heiko Trautmann

  • Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

    Felicitas Thol;Sofia Kade;Carola Schlarmann;Patrick Löffeld

  • Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation

    Aaheli Roy Choudhury;Zhenyu Ju;Meta W. Djojosubroto;Andrea Schienke

  • Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia

    Felicitas Thol;Frederik Damm;Andrea Lüdeking;Claudia Winschel

  • The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

    Sabine Kayser;Konstanze Döhner;Jürgen Krauter;Claus Henning Köhne

  • Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

    Erdogan Taskesen;Lars Bullinger;Andrea Corbacioglu;Mathijs A. Sanders

  • Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

    Letizia Venturini;Karin Battmer;Mirco Castoldi;Beate Schultheis

Frequent Co-Authors

Michael Heuser
Michael Heuser Hannover Medical School
Hartmut Döhner
Hartmut Döhner University of Ulm
Richard F. Schlenk
Richard F. Schlenk University Hospital Heidelberg
Konstanze Döhner
Konstanze Döhner University of Ulm
Brigitte Schlegelberger
Brigitte Schlegelberger Hannover Medical School
Michael Lübbert
Michael Lübbert University of Freiburg
Gudrun Göhring
Gudrun Göhring Hannover Medical School
Lars Bullinger
Lars Bullinger Charité - University Medicine Berlin
Arnon Nagler
Arnon Nagler Sheba Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degree options can be a practical way to fast-track your journey into the field of medicine or health care. Many students and professionals look for advanced pathways, such as online dnp programs, to gain specialized skills and leadership roles in nursing with flexible study options. These programs are ideal for nurses aiming to reach the highest levels of clinical practice without pausing their careers.

If you’re looking for an entry point into health care, fast track lpn programs can help you become a Licensed Practical Nurse quickly, offering streamlined online coursework designed to get you into the workforce sooner. For those interested in mental health, the shortest post master's pmhnp online programs provide a rapid route to certification as a psychiatric mental health nurse practitioner.

Affordability is also a concern for many prospective students. The cheapest online health science degree options enable you to balance cost with quality, opening doors to careers in health administration and support roles. Considering these pathways offers a range of options for advancing your healthcare career on your terms.

Best Scientists Citing Arnold Ganser

Trending Scientists

Recently Published Articles